Skip to main content
<p> Social media campaigns have successfully pressured drug companies to approve some requests for investigational drugs for terminally ill patients under expanded access programs, but this raises significant ethical concerns.</p>

Patients using social media to lobby for access to investigational drugs

Safety, hindered drug development are ethical concerns

Social media campaigns have successfully pressured drug companies to approve some requests for investigational drugs for terminally ill patients under expanded access programs, but this raises significant ethical concerns.